153 related articles for article (PubMed ID: 8550786)
21. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
22. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
Stewart LV; Weigel NL
Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft.
Gregory CW; Kim D; Ye P; D'Ercole AJ; Pretlow TG; Mohler JL; French FS
Endocrinology; 1999 May; 140(5):2372-81. PubMed ID: 10218991
[TBL] [Abstract][Full Text] [Related]
24. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
25. Expression patterns of insulin-like growth factor-binding proteins 1, 2, 3, 5, and 6 in the mid-cycle monkey ovary.
Arraztoa JA; Monget P; Bondy C; Zhou J
J Clin Endocrinol Metab; 2002 Nov; 87(11):5220-8. PubMed ID: 12414895
[TBL] [Abstract][Full Text] [Related]
26. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium.
Adesanya OO; Zhou J; Bondy CA
J Clin Endocrinol Metab; 1996 Jul; 81(7):2495-501. PubMed ID: 8675566
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor-binding proteins in R3230AC mammary tumors of intact and diabetic rats.
Korc-Grodzicki B; Ren N; Hilf R
Endocrinology; 1993 Nov; 133(5):2362-70. PubMed ID: 7691588
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-beta and retinoic acid in the human prostate adenocarcinoma cell line PC-3.
Hwa V; Oh Y; Rosenfeld RG
Endocrine; 1997 Jun; 6(3):235-42. PubMed ID: 9368678
[TBL] [Abstract][Full Text] [Related]
29. Expression study of three secretory proteins (prostatic secretory protein of 94 amino acids, probasin, and seminal vesicle secretion II) in dysplastic and neoplastic rat prostates.
Kwong J; Lui K; Chan PS; Ho SM; Wong YC; Xuan JW; Chan FL
Prostate; 2003 Jul; 56(2):81-97. PubMed ID: 12746832
[TBL] [Abstract][Full Text] [Related]
30. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: clinical correlations.
Thrasher JB; Tennant MK; Twomey PA; Hansberry KL; Wettlaufer JN; Plymate SR
J Urol; 1996 Mar; 155(3):999-1003. PubMed ID: 8583626
[TBL] [Abstract][Full Text] [Related]
33. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma.
Doganavsargil B; Simsir A; Boyacioglu H; Cal C; Hekimgil M
BJU Int; 2006 Mar; 97(3):644-8. PubMed ID: 16469041
[TBL] [Abstract][Full Text] [Related]
34. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization.
Batch JA; Mercuri FA; Edmondson SR; Werther GA
J Clin Endocrinol Metab; 1994 Nov; 79(5):1444-9. PubMed ID: 7525637
[TBL] [Abstract][Full Text] [Related]
35. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.
Kanety H; Madjar Y; Dagan Y; Levi J; Papa MZ; Pariente C; Goldwasser B; Karasik A
J Clin Endocrinol Metab; 1993 Jul; 77(1):229-33. PubMed ID: 7686915
[TBL] [Abstract][Full Text] [Related]
36. Expression of ezrin in prostatic intraepithelial neoplasia.
Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
[TBL] [Abstract][Full Text] [Related]
37. Analysis of IMP3 expression in prostate adenocarcinomas.
Tosun Yildirim H; Sentürk N
Turk Patoloji Derg; 2012; 28(2):128-33. PubMed ID: 22627630
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
39. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells.
Hwa V; Tomasini-Sprenger C; Bermejo AL; Rosenfeld RG; Plymate SR
J Clin Endocrinol Metab; 1998 Dec; 83(12):4355-62. PubMed ID: 9851777
[TBL] [Abstract][Full Text] [Related]
40. aFGF immunoreactivity in prostate cancer and its co-localization with bFGF and FGF8.
Dorkin TJ; Robinson MC; Marsh C; Neal DE; Leung HY
J Pathol; 1999 Dec; 189(4):564-9. PubMed ID: 10629559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
